ETHZilla Corp
For the period ended Sep 30, 2025. Filed Nov 14, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 14, 2025
FRMM$2.82-2.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
ETHZilla CORPORATIONformerly 180 LIFE SCIENCES CORP. AND SUBSIDIARIES
Condensed Consolidated Statements of Cash Flows
(Expressed in US Dollars)
| For the Nine Months Ended | ||||
|---|---|---|---|---|
| September 30, | ||||
| 2025 · 2024 | ||||
| Cash Flows from Operating Activities | ||||
| Net loss from continuing operations | $(212,008,038) | $(1,658,746) | ||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||
| Stock-based compensation | 208,922,667 | 274,826 | ||
| Change in fair value of derivative liabilities | - | (58) | ||
| Digital asset gains and losses | (7,549,815) | - | ||
| Change in fair value of available for sale securities | 74,788 | - | ||
| Non-cash settlement expense | (3,724,344) | - | ||
| Non-cash staking and incentive revenue | (4,110,169) | - | ||
| Gain loss on settlement of liabilities | - | (52,695) | ||
| Changes in operating assets and liabilities: | ||||
| Prepaid expenses and other current assets | (1,763,712) | 1,092,963 | ||
| Accounts payable | 785,392 | (143,939) | ||
| Accounts payable - related parties | (33,134) | 72,616 | ||
| Accrued expenses | 1,120,042 | (116,532) | ||
| Total adjustments | 193,721,715 | 1,127,181 | ||
| Net cash used in operating activities from continuing operations | (18,286,323) | (531,565) | ||
| Net cash used in operating activities from discontinued operations | (132,277) | (14,612) | ||
| Net cash used in operating activities | (18,418,600) | (546,177) | ||
| Cash Flows from Investing Activities | ||||
| Purchases of marketable securities | (8,890,596) | - | ||
| Purchases of digital assets | (243,479,818) | - | ||
| Net cash used in investing activities from continuing operations | (252,370,414) | - | ||
| Net cash used in investing activities from discontinued operations | - | - | ||
| Net cash used in investing activities | (252,370,414) | - | ||
| Cash Flows from Financing Activities | ||||
| Proceeds from exercise of pre-funded warrants from the Amendment to August 2023 Offering | - | 489 | ||
| Repayment of loans payable | (128,738) | (996,494) | ||
| Repayment of loans payable related parties | (1,000,000) | - | ||
| Treasury stock purchases | (16,121,428) | - | ||
| Proceeds from collateralized loan | 50,000,000 | - | ||
| Proceeds from convertible debt, net | 500,000,805 | - | ||
| Proceeds from exercise of common stock options | 74,320 | - | ||
| Proceeds from exercise of common stock warrants | 5,605,706 | - | ||
| Proceeds from shares issued for cash and warrants, net | 286,843,926 | - | ||
| Net cash provided by (used in) financing activities from continuing operations | 825,274,591 | (996,005) | ||
| Net cash used in financing activities from discontinued operations | (151,444) | (13,973) | ||
| Net cash provided by (used in) financing activities | 825,123,147 | (1,009,978) | ||
| Net Change In Cash, cash equivalents and restricted cash equivalents | 554,334,133 | (1,556,155) | ||
| Cash, cash equivalents and restricted cash equivalents - Beginning of Period | 4,567,251 | 1,706,292 | ||
| Cash, cash equivalents and restricted cash equivalents - End of Period | $558,901,384 | $150,137 | ||
| Supplemental Disclosures of Cash Flow Information: | ||||
| Cash paid during the period for income taxes | $ | - | $ | - |
| Cash paid during the period for interest expense | $ | - | $12,078 | |
| Non cash investing and financing activities | ||||
| Conversion of Series B Convertible Preferred Stock | $100 | $ | - | |
| Shares issued for settlement of liabilities | $751,406 | $523,251 | ||
| Prepaid expense financed with notes payable | $722,000 | $777,702 | ||
| Commitment to repurchase common stock | $1,000,000 | $ | - | |
| Warrants and Series B Convertible Preferred Stock issued for asset acquisition | $ | - | $7,622,041 | |
| ETH holdings contributed in exchange for common stock | $171,287,512 | $ | - | |
| Staking receivable | $256,931,437 | $ | - | |
| Cashless exercise of warrants | $13 | $ | - | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.